Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Sep 17 - Sep 22
glp-1 drugs heart failure Cardiovascular and mortality outcomes with receptor agonists vs other glucose-lowering in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia Structural insights into the Std Price Frequency:3 month supply
Structural insights into the activation of GLP-1R by a small molecule agonist | Cell Research
Mounjaro (tirzepatide): Manufactured by Eli Lilly and FDA-approved for type 2 diabetes, Mounjaro targets both GLP-1 and GIP receptors and has been widely prescribed off-label for weight loss
Std Price
Frequency:3 month supply
Side Effect Comparison Since both medications work through the same GLP-1 pathway, their side effect profiles are similar
US$ 20.37
US$ 26.17
US$ 23.58
US$ 26.98
US$ 28.81
US$ 22.22
US$ 23.41
